Co-designing better transitions in care for patients undergoing cancer treatment
Summary
Cancer treatment can be difficult and confusing, especially for those with head and neck cancer. These patients have to move between many providers to get treatment and care. But, moving between healthcare providers and settings affect patients care and consequently their health. There are different ways that have shown to improve care for patients with cancer as they move between healthcare providers and settings. These measures can also increase patients’ chance of having a positive outcome after the cancer treatment.
We will develop a care bundle with the help of head and neck cancer patients, healthcare providers and leaders .This bundle will help to improve the care and health of head and neck cancer patients. To do this, we will use a formal process for engaging these groups to develop the care bundle and to create a plan for implementation.
Eligibility
Eligible ages: 18 to 100
Inclusion criteria:
1. Adult, above 18 years old
2. Patients diagnosed with head and neck cancer or family members/caregivers for someone with head and neck cancer
3. Patients can be at any stage of cancer care (from diagnosis to survivorship)
4. Patients who have experienced a move or transition between medical providers or centres in Alberta
5. A medical professional who provides medical care to patients with cancer, at any stage of their cancer care
Exclusion criteria:
1. Patients younger than 18 years old
2. Patients who have not had head and neck cancer themselves or have not been a caregiver or family member to someone with head and neck cancer
3. Patients who have not moved or transitioned their care between medical care providers or centers
4. Patients who received their cancer care outside of Alberta
5. Medical providers that have not cared for patients with cancer
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Recruitment will be directed to the Principal Investigator of this study.
Principal investigator:
Khara Marissa Sauro
Clinical trial:
No
REB-ID:
HREBA.CC-24-0305